Results 1-20 of 34 for hpv speaker:Clare Daly

Written Answers — Department of Health: Vaccination Programme Data (26 Mar 2019)

Clare Daly: 800. To ask the Minister for Health the details of the HPV immunisation uptake statistics provided by the HSE Health Protection Surveillance Centre for the school year 1 September 2017 to 1 June 2018; and if he will make a statement on the matter. [13523/19]

Written Answers — Department of Health: Vaccination Programme Data (26 Mar 2019)

Clare Daly: 801. To ask the Minister for Health the number of suspected adverse reactions to the HPV vaccine reported to the Health Products Regulatory Authority, HPRA, as at 31 December 2018; the number of cases reported; the number of system organ class reactions reported; the percentage of cases categorised as serious; the number of cases unresolved; and the regular intervals the HPRA is required to...

Written Answers — Department of Health: Vaccination Programme (26 Feb 2019)

Clare Daly: 399. To ask the Minister for Health the way in which the Health Products Regulatory Authority plans to monitor the safety of the HPV vaccine Gardasil 9 as a black triangle product; if it is to be administered to girls and boys here simultaneously with other vaccines as proposed by HIQA in its health technology assessment on extending the HPV vaccination to boys; and if he will make a...

Written Answers — Department of Health: Vaccination Programme (26 Feb 2019)

Clare Daly: ...for Health his views on the use by HIQA of Norwegian health technology assessment local data in the absence of validated Irish data on hospitalisation rates for the associated adverse events of the HPV vaccine (details supplied); and if he will make a statement on the matter. [9583/19]

Written Answers — Department of Health: Vaccination Programme (26 Feb 2019)

Clare Daly: 401. To ask the Minister for Health his views on the HIQA health technology assessment report on extending the HPV vaccine to boys (details supplied); if HIQA included studies in its review that did not conform with the EU, EMA, HPRA, FDA and WHO definition of a serious adverse event; and if so, the definition of such an event HIQA used to select relevant international literature for the...

National Cervical Screening Programme: Statements (6 Feb 2019)

Clare Daly: ...undertake any serious scrutiny on these matters, they are just interested in a cheap headline. The latest scandal is around writing to these 4,600 women as a result of the delay in checking for HPV in one lab outside the debate. The media is asking how these women are supposed to feel. I am in the middle of the screening process and I do not feel especially great about this, nobody...

Written Answers — Department of Health: Cancer Screening Programmes (30 Jan 2019)

Clare Daly: 207. To ask the Minister for Health if the roll-out of the new and more accurate HPV screening test for cervical cancer has been impacted or delayed by the controversy over the disclosure of cervical screening audit results in May 2018. [4638/19]

Written Answers — Department of Health: Vaccination Programme (29 Jan 2019)

Clare Daly: 310. To ask the Minister for Health the reason HIQA in its HTA report on extending the HPV vaccine to boys published in December 2018 used a Norwegian definition of a serious adverse reaction instead of the EU/EMA/HPRA definition of a serious adverse reaction as set out in guidelines (details supplied). [3765/19]

Written Answers — Department of Health: Vaccination Programme (24 Oct 2018)

Clare Daly: 253. To ask the Minister for Health the expenditure on the advertising and promoting of the HPV vaccine in each of the years 2014 to 2017. [44155/18]

Written Answers — Department of Health: Vaccination Programme Data (25 Sep 2018)

Clare Daly: 272. To ask the Minister for Health if his Department or the HSE have obtained all the research behind the Gardasil HPV vaccines research trial data; and if he will make a statement on the matter. [38353/18]

Written Answers — Department of Health: Vaccination Programme Data (26 Jun 2018)

Clare Daly: 361. To ask the Minister for Health the number of doses of the HPV vaccine administered here to date; and the number of cases of anaphylactic or anaphylactoid reactions reported to the HPRA within the first three years of the vaccine being administered through the school system, that is between 1 September 2010 and 1 June 2013, before the number of vaccine doses per patient was reduced from...

Written Answers — Department of Health: Vaccination Programme (13 Jun 2018)

Clare Daly: 122. To ask the Minister for Health the number and type of seizures and suspected adverse reactions to the HPV vaccine reported to the HPRA; and if he will make a statement on the matter. [25807/18]

Written Answers — Department of Health: HIV-AIDS Programmes (13 Jun 2018)

Clare Daly: 123. To ask the Minister for Health his views on the HSE promotional campaign for the HPV vaccine which contains captions such as armed for life and protect our future and states that the HPV vaccine protects girls from getting cervical cancer when they are older in view of information (details supplied); and if he will make a statement on the matter. [25808/18]

Written Answers — Department of Health: Vaccination Programme (30 May 2018)

Clare Daly: 138. To ask the Minister for Health the reason cases of suspected adverse reactions to the HPV vaccine Gardasil previously listed as convulsions were recently amended on the HPRA line listing report to seizures; if these amendments were notified to the EMA EudraVigilance database; if the attention of the case ID patient holder is drawn to such changes to their records; and if he will make a...

Written Answers — Department of Health: Vaccination Programme (30 May 2018)

Clare Daly: 139. To ask the Minister for Health his views on the long-term protection provided by the HPV vaccine Gardasil in view of information (details supplied); if a booster dose will be required; and if he will make a statement on the matter. [23837/18]

Written Answers — Department of Health: Vaccination Programme (30 May 2018)

Clare Daly: 140. To ask the Minister for Health the reason the HSE failed to provide parents with the HPV vaccine Gardasil manufacturer's package leaflet in the HSE parent information packs which promote the vaccine, particularly in view of the disclaimer contained on the HSE's website; and if he will make a statement on the matter. [23838/18]

National Cervical Screening Programme: Statements (1 May 2018)

Clare Daly: The Minister said there is a better system now, the HPV testing, which has been assessed and will be implemented. When was it decided to assess that and move to the new system and what was the basis of that reassessment?

Written Answers — Department of Health: Vaccination Programme (17 Apr 2018)

Clare Daly: 946. To ask the Minister for Health the training programmes provided by his Department to general practitioners in detecting adverse reactions to the HPV vaccine; the directive under which general practitioners have to report or not report their findings in view of the initial figures for 2011 and 2012, as already published; and if he will make a statement on the matter. [16285/18]

Written Answers — Department of Health: Vaccination Programme Data (17 Apr 2018)

Clare Daly: 947. To ask the Minister for Health the number of adverse reactions to the HPV vaccine reported by general practitioners to the HPRA in each of the years 2011 to 2017; and if he will make a statement on the matter. [16286/18]

HPV Vaccine: Motion [Private Members] (28 Mar 2018)

Clare Daly: ...To insert the following words after "secondary school; and":"calls on the Government to: — instruct the HSE to engage with those who have experienced health problems in the time period after receiving the HPV vaccine in order to determine the cause of that damage; — ensure proper medical and other support is available to those who have suffered health problems in the time...